We are live on ! Find out more
PRC

Platte River Capital Portfolio holdings

AUM $108M
1-Year Est. Return 0.26%
This Fund
S&P 500
This Quarter Est. Return
+9.82%
1 Year Est. Return
-0.26%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$780M
AUM Growth
-$30.9M
Cap. Flow
-$95.7M
Cap. Flow %
-12.27%
Top 10 Hldgs %
21.67%
Holding
243
New
41
Increased
37
Reduced
116
Closed
34

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$6.51M
2
GILD icon
Gilead Sciences
GILD
+$6.38M
3
ISRG icon
Intuitive Surgical
ISRG
+$6.28M
4
EXC icon
Exelon
EXC
+$5.8M
5
MDT icon
Medtronic
MDT
+$5.27M

Sector Composition

Rank Sector Weight
1 Healthcare 19.97%
2 Technology 16.47%
3 Energy 12.98%
4 Financials 11.71%
5 Consumer Staples 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
51
Emerson Electric
EMR
$82.9B
$5.21M 0.67%
74,210
-9,520
-11% -$636K
CIEN icon
52
Ciena
CIEN
$55.3B
$5.15M 0.66%
215,120
-66,680
-24% -$1.59M
TM icon
53
Toyota
TM
$210B
$4.98M 0.64%
40,830
-15,345
-27% -$1.93M
ALTR
54
DELISTED
Altera Corp
ALTR
$4.92M 0.63%
151,300
+58,690
+63% +$1.96M
HIG icon
55
Hartford Financial Services
HIG
$38.5B
$4.68M 0.6%
129,080
-15,310
-11% -$527K
VMC icon
56
Vulcan Materials
VMC
$36.3B
$4.67M 0.6%
78,560
-14,560
-16% -$804K
VIAV icon
57
Viavi Solutions
VIAV
$9.75B
$4.66M 0.6%
630,261
+53,813
+9% +$409K
C icon
58
Citigroup
C
$222B
$4.63M 0.59%
88,870
-1,360
-2% -$68.8K
BSX icon
59
Boston Scientific
BSX
$65.8B
$4.63M 0.59%
384,930
-56,740
-13% -$670K
SCHW
60
Charles Schwab
SCHW
$177B
$4.58M 0.59%
176,360
-27,500
-13% -$656K
MRO
61
DELISTED
Marathon Oil Corporation
MRO
$4.58M 0.59%
+129,780
New +$4.63M
GLW icon
62
Corning
GLW
$126B
$4.55M 0.58%
255,310
-57,115
-18% -$941K
HSP
63
DELISTED
HOSPIRA INC
HSP
$4.53M 0.58%
109,620
-40,960
-27% -$1.65M
RIG icon
64
Transocean
RIG
$5.92B
$4.52M 0.58%
+91,520
New +$4.48M
SU icon
65
Suncor Energy
SU
$77.7B
$4.49M 0.58%
128,195
-20,000
-13% -$703K
MDRX
66
DELISTED
Veradigm Inc. Common Stock
MDRX
$4.42M 0.57%
285,980
+126,610
+79% +$1.87M
FWLT
67
DELISTED
FOSTER WHEELER AG (SWITZERLAND)
FWLT
$4.38M 0.56%
132,855
-15,000
-10% -$439K
WMGI
68
DELISTED
Wright Medical Group Inc
WMGI
$4.33M 0.55%
140,850
-14,000
-9% -$396K
TWTC
69
DELISTED
TW TELECOM INC CL A COM
TWTC
$4.03M 0.52%
132,200
+23,920
+22% +$713K
LLY icon
70
Eli Lilly
LLY
$1.07T
$3.96M 0.51%
77,660
-4,700
-6% -$235K
AVP
71
DELISTED
Avon Products, Inc.
AVP
$3.92M 0.5%
227,765
-46,135
-17% -$862K
TRV icon
72
Travelers Companies
TRV
$80.8B
$3.81M 0.49%
42,070
-4,570
-10% -$399K
ALLT icon
73
Allot
ALLT
$374M
$3.79M 0.49%
250,450
+58,700
+31% +$797K
IX icon
74
ORIX
IX
$44B
$3.78M 0.49%
212,230
-30,615
-13% -$524K
QLIK
75
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
$3.78M 0.48%
141,930
-20
-0% -$552

Similar funds

Platte River Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Platte River Capital held 243 positions worth $780M, down 3.8% from $811M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Platte River Capital withdrew a net $95.7M in Q4 2013, closing 34 positions and reducing 116 holdings. Its most notable exit was Baxter International, an estimated $6.51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 22% a quarter earlier, followed by Technology and Energy.

Against the trend, Platte River Capital opened a new position in SLM Corp worth $5.27M.

  • Platte River Capital's largest Q4 2013 buy was SLM Corp: 561,503 shares worth $5.27M.
  • Platte River Capital added most to Caterpillar in Q4 2013, an estimated $2.54M increase.
  • Platte River Capital's biggest Q4 2013 reduction was Gilead Sciences, cutting an estimated $6.38M.
  • Platte River Capital fully exited Baxter International in Q4 2013, selling an estimated $6.51M.
  • Platte River Capital's ten largest holdings make up 22% of its $780M portfolio in Q4 2013.
  • Platte River Capital opened 41 new positions and closed 34 in Q4 2013.
  • Platte River Capital's portfolio value fell 3.8% quarter-over-quarter to $780M.

Based on Platte River Capital's 13F filing for Q4 2013, filed 4 Feb 2014.